These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35531461)
41. Tissue plasminogen activator for postvitrectomy fibrin formation. Jaffe GJ; Abrams GW; Williams GA; Han DP Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297 [TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage. Mayer WJ; Hakim I; Haritoglou C; Gandorfer A; Ulbig M; Kampik A; Wolf A Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010 [TBL] [Abstract][Full Text] [Related]
44. Cataractous changes due to posterior chamber flattening with a posterior chamber phakic intraocular lens secondary to the administration of pilocarpine. Maldonado MJ; García-Feijoó J; Benítez Del Castillo JM; Teutsch P Ophthalmology; 2006 Aug; 113(8):1283-8. PubMed ID: 16766030 [TBL] [Abstract][Full Text] [Related]
45. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis. Wu TT; Wang HH Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882 [TBL] [Abstract][Full Text] [Related]
46. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion. Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208 [TBL] [Abstract][Full Text] [Related]
47. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR; Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191 [TBL] [Abstract][Full Text] [Related]
48. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790 [TBL] [Abstract][Full Text] [Related]
49. Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis. Baziuk N; Fang T; Peyman GA; Gremillion CM Int Ophthalmol; 1991 Mar; 15(2):79-86. PubMed ID: 1902438 [TBL] [Abstract][Full Text] [Related]
50. AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber. Payá EM; González MA; Ortuño MR; Corell PML; Arteaga JV; Llopis MD Rom J Ophthalmol; 2022; 66(2):191-192. PubMed ID: 35935083 [TBL] [Abstract][Full Text] [Related]
51. [Intraocular rt-PA injection in fibrin formation after combined glaucoma and cataract operation]. Steinkamp GW; Heider W; Schalnus R; Hattenbach LO Ophthalmologe; 1996 Oct; 93(5):558-60. PubMed ID: 9004880 [TBL] [Abstract][Full Text] [Related]
52. Trypan blue as an adjunct for safe phacoemulsification in eyes with white cataract. Jacob S; Agarwal A; Agarwal A; Agarwal S; Chowdhary S; Chowdhary R; Bagmar AA J Cataract Refract Surg; 2002 Oct; 28(10):1819-25. PubMed ID: 12388035 [TBL] [Abstract][Full Text] [Related]
54. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis. Koerner F; Boehnke M Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641 [TBL] [Abstract][Full Text] [Related]
55. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin. Zwaan J; Latimer WB Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569 [TBL] [Abstract][Full Text] [Related]
56. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations]. Heiligenhaus A; Schilling H; Schilling M; Mellin KB Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161 [TBL] [Abstract][Full Text] [Related]
57. Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome. Hong BK; Francis BA Digit J Ophthalmol; 2013; 19(2):21-3. PubMed ID: 24109245 [TBL] [Abstract][Full Text] [Related]
58. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach]. Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136 [TBL] [Abstract][Full Text] [Related]
59. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Seifert V; Eisert WG; Stolke D; Goetz C Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953 [TBL] [Abstract][Full Text] [Related]